News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

AGENUS OFFERS AN INVESTMENT OPPORTUNITY.

  Saturday, September 07, 2013

 More...


Recent Postings


Archive


Tags

Agenus (AGEN) GUARDIAN HEALTH Ariad (ARIA) Pluristem (PSTI) Bellicum (BLCM) OncoCyte (OCX) Merck (MRK) Prosensa (RNA) CEMPRA (CEMP) Amgen (AMGN) Biogen Idec (BIIB) Sanofi (SNA) Anacor (ANAC) PTC Therapeutics (PTCT) Revlimid (lenolidamide) Intermune (ITMN) RenenxBio (RGNX) Theravance (THRX) Human Genome Sciences (HGSI) Aimmune Therapeutics (AIMT) Inovio (INO) Cytokinetics (CYTK) ADVENTRIX (ANX) TOKAI (TKAOI) Agenus (AGEN C4 Therapeutics Alnylam (ALNY) Sanofi (SNY) CRISPR Therapeutics (CRSP) Vitae Pharmaceuticals (VTAE) VANDA (VNDA) Ocular Therapeutix (OCUL) Spike Therapeutics (ONCE) ARCA (ABIO) GlaxoSmithKline (GSK) Intercept (ICPT) Dynavax (DVAX) Zerenex Prolor Biotech (PBTH) Onyx (ONXX) Advaxis (ADXS) Theravance Bio Pharma (TBPH) Seattle Genetics (SGEN) PORTOLA (PTLA) NANTKWEST (NK) Micromet (MITI) Sangamo (SGMO) Tysabri Adaptimmune (ADAP) Sequenom (SQNM) Mirati Therapeutics (MRTX) Ridaforolimus KERYX (KERX) BIOMARIN (BMRN) SUNESIS PHARMACEUTICALS (SNSS) Gilead (GILD) Abbott Laboratories (ABT) Ziofpharm (ZIOP) Roche (ROCHE) Herceptin Galena (GALE) Elan (ELN) Jazz Pharmaceuticals (JAZZ) JUNO (JUNO) OSI (OSIP) LEXICON (LXRX) galapagos (GLPG) ISIS (ISIS) Anadys (ANDS) Valeant Pharmaceuticals International (VRX) HALOZYME (HALO) Exelixis (EXEL) Dendreon (DNDN) Sarepta (SRPT) ImmunoGen (IMGN) Velcade (bortezomib) Editas (EDIT) Intrexon (XON) NEKTAR (NKTR)) SYNTA (SNTA) MODERNA Roche (RHHBY) JOUNCE THERAPEUTICS (JNCE) SERES THERAPEUTICS (MCRB) ARGOS (ARGS) Incyte (INCY) Ionis (IONS) Genentech Telaprevir IDERA (IDRA) Human Longevity (HLI) Idenix (IDIX) AGOS (ARGS) Benlysta (belimumab) Auspex (ASPX) REGULUS (RGLS) Trastuzumab-DM1 CompuGen (CGEN) AERIE PHARMACEUTICALS AstraZeneca (AZN) Xoma (XOMA) Biocryst (BCRX) ZALTRAP™ Bristol-Myers Squibb (BMY) Alder Biopharmaceuticals (ALDR) Endometrial Cancer Illumina (ILMN) Rapamune Multiple Myeloma INNOVIVA (INVA) Sanofi-Aventis (SAN) KITE (KITE) NOVOCURE (NVCR) Array Pharmaceuticals (ARRY) ACADIA (ACAD) Global Cell Therapeutics (GBT) ABBVIE (ABBV) Vertex (VRTX) Regeneron (REGN)